Package 62175-270-41

{"route": ["ORAL"], "spl_id": "72bbc7a8-711b-47a6-8152-9409f4068929", "openfda": {"unii": ["L9F3D9RENQ"], "rxcui": ["863619", "863628", "863636"], "spl_set_id": ["c5950dba-d92b-46a0-993f-af9f9ddb52bf"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-37)", "package_ndc": "62175-270-37", "marketing_start_date": "20090301"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-41)", "package_ndc": "62175-270-41", "marketing_start_date": "20090301"}], "brand_name": "Oxybutynin Chloride Extended Release", "product_id": "62175-270_72bbc7a8-711b-47a6-8152-9409f4068929", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "62175-270", "generic_name": "Oxybutynin Chloride", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxybutynin Chloride", "brand_name_suffix": "Extended Release", "active_ingredients": [{"name": "OXYBUTYNIN CHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA078503", "marketing_category": "ANDA", "marketing_start_date": "20090301", "listing_expiration_date": "20261231"}